These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 37765223)

  • 1. Modulation of Human Dendritic Cell Functions by Phosphodiesterase-4 Inhibitors: Potential Relevance for the Treatment of Respiratory Diseases.
    Nguyen HO; Tiberio L; Facchinetti F; Ripari G; Violi V; Villetti G; Salvi V; Bosisio D
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation.
    Nguyen HO; Salvi V; Tiberio L; Facchinetti F; Govoni M; Villetti G; Civelli M; Barbazza I; Gaudenzi C; Passari M; Schioppa T; Sozio F; Del Prete A; Sozzani S; Bosisio D
    J Transl Med; 2022 May; 20(1):203. PubMed ID: 35538539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs.
    Nguyen HO; Schioppa T; Tiberio L; Facchinetti F; Villetti G; Civelli M; Del Prete A; Sozio F; Gaudenzi C; Passari M; Barbazza I; Sozzani S; Salvi V; Bosisio D
    Front Immunol; 2021; 12():797390. PubMed ID: 35140709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10.
    Bros M; Montermann E; Cholaszczyńska A; Reske-Kunz AB
    Int Immunopharmacol; 2016 Jun; 35():174-184. PubMed ID: 27070502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PDE4 inhibitor CHF6001 modulates pro-inflammatory cytokines, chemokines and Th1- and Th17-polarizing cytokines in human dendritic cells.
    Gianello V; Salvi V; Parola C; Moretto N; Facchinetti F; Civelli M; Villetti G; Bosisio D; Sozzani S
    Biochem Pharmacol; 2019 May; 163():371-380. PubMed ID: 30851246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase 4 inhibitors reduce human dendritic cell inflammatory cytokine production and Th1-polarizing capacity.
    Heystek HC; Thierry AC; Soulard P; Moulon C
    Int Immunol; 2003 Jul; 15(7):827-35. PubMed ID: 12807821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity.
    Jensen SS; Gad M
    J Inflamm (Lond); 2010 Jul; 7():37. PubMed ID: 20663192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
    Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
    J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.
    López-Bravo M; Minguito de la Escalera M; Domínguez PM; González-Cintado L; del Fresno C; Martín P; Martínez del Hoyo G; Ardavín C
    J Allergy Clin Immunol; 2013 Dec; 132(6):1409-19. PubMed ID: 24139608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
    Carenza C; Calcaterra F; Oriolo F; Di Vito C; Ubezio M; Della Porta MG; Mavilio D; Della Bella S
    Front Immunol; 2019; 10():1325. PubMed ID: 31244860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Proinflammatory Cytokines in Monocyte-Derived Dendritic Cells by Porcine Reproductive and Respiratory Syndrome Virus Through Interaction with the Porcine Intercellular-Adhesion-Molecule-3-Grabbing Nonintegrin.
    Piñeyro PE; Subramaniam S; Kenney SP; Heffron CL; Giménez-Lirola LG; Meng XJ
    Viral Immunol; 2016 Dec; 29(10):546-556. PubMed ID: 27643915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.
    Kim NS; Torrez T; Langridge W
    Cell Immunol; 2019 Apr; 338():32-42. PubMed ID: 30910218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases.
    Bielekova B; Lincoln A; McFarland H; Martin R
    J Immunol; 2000 Jan; 164(2):1117-24. PubMed ID: 10623864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity.
    Moret FM; Hack CE; van der Wurff-Jacobs KM; de Jager W; Radstake TR; Lafeber FP; van Roon JA
    Arthritis Res Ther; 2013 Oct; 15(5):R155. PubMed ID: 24286358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide.
    Yamamoto K; Kitawaki T; Sugimoto N; Fujita H; Kawase Y; Takaori-Kondo A; Kadowaki N
    Immunol Lett; 2019 Jul; 211():41-48. PubMed ID: 31141702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells.
    Olivar R; Luque A; Cárdenas-Brito S; Naranjo-Gómez M; Blom AM; Borràs FE; Rodriguez de Córdoba S; Zipfel PF; Aran JM
    J Immunol; 2016 May; 196(10):4274-90. PubMed ID: 27076676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
    Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
    J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Ilic N; Gruden-Movsesijan A; Cvetkovic J; Tomic S; Vucevic DB; Aranzamendi C; Colic M; Pinelli E; Sofronic-Milosavljevic L
    Front Immunol; 2018; 9():11. PubMed ID: 29416536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.